|
1.
|
Review article
|
De-escalation of perioperative systemic therapy for early breast cancer. 2026/08
|
|
2.
|
Original article
|
Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor-normal paired sequencing study. 2026/07
|
|
3.
|
Original article
|
Tumor Lineage–Specific Disparities in Access to Genome-Matched Therapies Among Adolescents and Young Adults in Japan: A Nationwide Genomic Profiling Study 2026/07
|
|
4.
|
Original article
|
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC. 2026/03
|
|
5.
|
Case report
|
NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib. 2026/01
|
|
6.
|
Case report
|
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain (A641R) mutation that respond to selpercatinib: a case report with review of literature 2025/07/10
|
|
7.
|
Original article
|
Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer 2025/06/13
|
|
8.
|
Original article
|
Appearance-related needs and challenges among cancer patients undergoing systemic therapy: a comprehensive survey study. 2025/03
|
|
9.
|
Original article
|
Prognostic Impact of Stimulator of Interferon Genes Expression in Triple Negative Breast Cancer 2025/02
|
|
10.
|
Original article
|
Barriers to career development and gender-related challenges in oncology: the results of the JSMO and JSCO surveys in Japan 2025
|
|
11.
|
Original article
|
Clinical potential of antibody–drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors 2025
|
|
12.
|
Original article
|
Enfortumab vedotin in patients with previously treated advanced breast cancer in the Phase 2 EV-202 study 2025
|
|
13.
|
Original article
|
Gemcitabine-based chemotherapy for advanced soft tissue sarcoma: identifying the appropriate dose and schedule 2024/12/21
|
|
14.
|
Case report
|
Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report 2024/12/20
|
|
15.
|
Original article
|
Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers. 2024/08
|
|
16.
|
Original article
|
Outcomes in nonmetastatic hormone receptor-positive HER2-negative pure mucinous breast cancer: A multicenter cohort study 2024/05/14
|
|
17.
|
Original article
|
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib 2024/04/30
|
|
18.
|
Original article
|
Assessment of pazopanib-related heart failure in patients with advanced soft tissue sarcoma - A single institute analysis 2024/01/25
|
|
19.
|
Case report
|
Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report 2023/08/31
|
|
20.
|
Original article
|
First-in-human study of E7130 (a tumor microenvironment-ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose-escalation part 2023/08/01
|
|
21.
|
Original article
|
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin 2023/06
|
|
22.
|
Original article
|
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study 2023/03/01
|
|
23.
|
Original article
|
Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck 2023
|
|
24.
|
Case report
|
Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging 2022/12/13
|
|
25.
|
Original article
|
Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer 2022/11
|
|
26.
|
Original article
|
Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories 2022/06
|
|
27.
|
Original article
|
Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort 2022/06
|
|
28.
|
Original article
|
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer 2022/05
|
|
29.
|
Original article
|
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients 2022/04
|
|
30.
|
Original article
|
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis 2022/03/17
|
|
31.
|
Original article
|
Post-systemic chemotherapy prognoses of recurrent/metastatic soft tissue sarcoma patients with retroperitoneal/intra-abdominal origin versus those with extremities/trunk origin 2022
|
|
32.
|
Case report
|
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor 2021/12/24
|
|
33.
|
Original article
|
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma 2021/12/14
|
|
34.
|
Original article
|
Clinical impact of cachexia in head and neck cancer patients who received chemoradiotherapy 2021/11/08
|
|
35.
|
Original article
|
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma 2021/11
|
|
36.
|
Original article
|
A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer 2021/10/26
|
|
37.
|
Original article
|
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors 2021/08
|
|
38.
|
Original article
|
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel 2021/08
|
|
39.
|
Original article
|
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma 2021/07/03
|
|
40.
|
Original article
|
Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy 2021/06/28
|
|
41.
|
Original article
|
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients 2021/06/28
|
|
42.
|
Original article
|
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma 2021/06/26
|
|
43.
|
Case report
|
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome 2021/04
|
|
44.
|
Original article
|
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients 2021/04
|
|
45.
|
Original article
|
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer 2021/03/04
|
|
46.
|
Original article
|
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib 2021/03
|
|
47.
|
Original article
|
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line 2021/01
|
|
48.
|
Original article
|
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma 2021/01
|
|
49.
|
Original article
|
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel 2020/11/21
|
|
50.
|
Case report
|
An extragonadal germ cell tumor with dermatomyositis: A case report and literature review 2020/11
|
|
51.
|
Original article
|
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib 2020/09
|
|
52.
|
Original article
|
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial 2020/06
|
|
53.
|
Original article
|
Long Non-coding NR2F1-AS1 is Associated with Tumor Recurrence in Estrogen Receptor-positive breast cancers 2020/05/11
|
|
54.
|
Original article
|
Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma 2020/04/08
|
|
55.
|
Original article
|
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer 2020/04
|
|
56.
|
Original article
|
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib 2020/03
|
|
57.
|
Original article
|
Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma 2019/09
|
|
58.
|
Original article
|
Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution 2018/04/18
|
|
59.
|
Original article
|
Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer 2017/05/02
|
|
60.
|
Original article
|
Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer with a Low Ki-67 Labeling Index 2017/02
|
|
61.
|
Original article
|
A novel combination of serum microRNAs for detecting breast cancer in the early stage 2016/03
|
|
62.
|
Original article
|
Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1 2015/06/12
|
|
63.
|
Original article
|
The expression and clinical significance of ribophorin II (RPN2) in human breast cancer 2015/06
|
|
64.
|
Original article
|
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier 2015/04
|
|
65.
|
Original article
|
Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers 2015/03
|
|
66.
|
Original article
|
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells 2014/07
|
|
67.
|
Review article
|
Exosome in disease biology, diagnosis, and therapy 2014
|
|
68.
|
Review article
|
Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment 2013/03
|
|
69.
|
Original article
|
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer 2012
|
|
70.
|
Original article
|
A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer 2011
|
|
71.
|
Review article
|
Cancer Stem Cells in Breast Cancer 2011
|
|
72.
|
Original article
|
Second-line chemotherapy in patients with primary unknown cancer 2011
|
|
73.
|
Original article
|
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer 2010
|
|
74.
|
Original article
|
Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy 2010
|
|
75.
|
Original article
|
Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors 2010
|
|
76.
|
Original article
|
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer 2009
|
|
77.
|
Original article
|
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy 2009
|
|
78.
|
Case report
|
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma 2009
|
|
79.
|
Original article
|
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine 2008
|
|
80.
|
Original article
|
Immunohistochemical profiles of brain metastases from breast cancer 2008
|
|
81.
|
Case report
|
Nocardia exalbida brain abscess in a patient with follicular lymphoma 2008
|
|
82.
|
Case report
|
Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer 2008
|
|
83.
|
Case report
|
MRCP and ERCP in Lemmel syndrome 2005
|
|
Display 5 items
|
|
Display all(83)
|